Alliance for Clinical Trials in Oncology clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
18 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 15 with minor changes only.
- Notable: Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects Primary and study completion pushed from Oct 1, 2026 to Oct 1, 2027
- Minor: HOPE · High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer Trial sites expanded: 212 → 216 locations
- Minor: Collecting Blood Samples From · and Without Cancer to Evaluate Tests for Early Cancer Detection Trial sites expanded: 747 → 751 locations
- Minor: Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young · Cancer Trial sites expanded: 324 → 327 locations
- Minor: Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays Trial sites expanded: 368 → 398 locations
- Minor: DEFEND · Distance-Based Exercise to Preserve Function and Prevent Disability Trial sites expanded: 23 → 30 locations
- Minor: Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer Trial sites expanded: 152 → 177 locations
- Minor: STRIKE · Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer Trial sites expanded: 425 → 429 locations
- Minor: Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL Trial sites expanded: 224 → 261 locations
- Minor: MFOLFIRINOX Versus mFOLFOX With or Without Nivolumab · Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma Trial sites expanded: 798 → 802 locations
- Minor: Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib · Previously Untreated Mantle Cell Lymphoma Trial sites expanded: 238 → 242 locations
- Minor: Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on · Advanced Prostate Cancer, RECIPROCAL Trial Trial sites expanded: 138 → 142 locations
- Minor: Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment Trial sites expanded: 111 → 125 locations
- Minor: Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial Trial sites expanded: 189 → 195 locations
- Minor: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib · Progressive Meningiomas Trial sites expanded: 784 → 791 locations
- Minor: Family Communications After Genetic Testing Trial sites expanded: 360 → 365 locations
- Notable: Genetic Testing in Guiding Treatment · Brain Metastases Results posted: Oct 30, 2026
- Notable: SHARES · Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions Results posted: Oct 27, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-22 | NCT07887984 Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly… | Phase 2/3 | Not Yet Recruiting |
Active trials by phase
| Phase 2 | 18 | |
| Phase 2/3 | 6 | |
| Phase 3 | 34 |
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 32
Breast Cancer (16) · Colorectal Cancer (9) · Prostate Cancer (8) · Leukemia (7) · Lung Cancer (6) · Acute Lymphoblastic Leukemia (ALL) (5) · Bladder Cancer (5) · Head & Neck Cancer (5) · Esophageal Cancer (4) · Gastric Cancer (4)
Get alerts when Alliance for Clinical Trials in Oncology's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.